Starpharma Holdings Limited announces that after nearly 17 years with the Company Mr. Nigel Baade, has advised of his intention to leave Starpharma as Company Secretary in early 2023 to pursue new professional opportunities. Starpharma has commenced an executive search process for a new Company Secretary. Mr. Baade will assist the Company in the transition until March 2023, completing the half year financial results.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | +4.35% | 0.00% | -29.41% |
Apr. 08 | Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16% | MT |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.41% | 30.3M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- SPL Stock
- News Starpharma Holdings Limited
- Starpharma Holdings Limited Announces Resignation of Nigel Baade as Company Secretary